To explore the effect of probiotics combined with budesonide and ipratropium bromide in the treatment of chronic obstructive pulmonary disease (COPD) on lung function and gut microbiota. This was a retrospective study of prospectively collected clinical data of 118 patients with COPD admitted to our hospital between January 2020 and December 2022. According to the treatment records, 59 patients received budesonide and irpratropium bromide (control group), and 59 patients received probiotics combined with budesonide and irpratropium bromide (observation group).
View Article and Find Full Text PDFObjective: This research was aimed to evaluate the impact of high-quality nursing (HQN) plus respiratory training on treatment compliance, pulmonary function (PF) and quality of life (QoL) of patients with chronic obstructive pulmonary disease (COPD).
Methods: We retrospectively analyzed 89 COPD patients who were treated at the affiliated Nanhua Hospital from February 2019 to February 2021. Among them, 40 cases received drug treatment and breathing training as the control group, and 49 cases were supplemented with HQN as the experimental group on the basis of the control group.
Evid Based Complement Alternat Med
August 2021
Angiotensin-converting enzyme 2 (ACE2) has been identified as the key receptor of SARS coronavirus that plays a key role in the pathogenesis of SARS. It is known that ACE2 mRNA can be expressed in most organs. However, the protein expression of ACE2 is not clear yet.
View Article and Find Full Text PDFNeutrophils are the first barriers for resisting the invasion, proliferation, and damage caused by Salmonella Typhimurium. However, the mechanisms that control this resistance are not completely understood. In this study, we established an in vitro Salmonella infection model in porcine neutrophils, and analyzed the cellular transcriptome by deep sequencing and flow cytometry.
View Article and Find Full Text PDF